LSX World Congress
3-4 May 2023
Business Design Centre, London
PrecisionLife techbio Co-founder and Chief Business & Investment Officer, Rowan Gardner, joins fellow senior decision makers from the world's most innovative biopharma, medtech and healthtech companies at LSX World Congress.
Techbio partnering opportunity
Partner with PrecisionLife at LSX World Congress to access the deepest precision medicine insights in over 45 complex chronic diseases.
We've generated a pipeline of drug discovery IP in the form of novel drug targets matched to patient biology and biomarkers to derisk clinical trials and develop companion diagnostic tools - accelerating approvals of new drugs and deploying the latest medicines to the right patients more quickly.
Login to LSX partnering to connect with Rowan at the congress or contact us to find out more about PrecisionLife.
